Angiotensin II decreases the renal MRI blood oxygenation level-dependent signal

Hypertension

Volumn 47, Issue 6, 2006, Pages 1062-1066

  Schachinger, Hartmut ^a,b   Klarhöfer, Markus ^b   Linder, Lilly ^b   Drewe, Jürgen ^b   Scheffler, Klaus ^b  

^a UNIVERSITY OF TRIER   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Angiotensin II; Blood pressure; Kidney; Magnetic resonance imaging; Nitroprusside; Norepinephrine

Indexed keywords

ANGIOTENSIN II; NITROPRUSSIDE SODIUM; NORADRENALIN; OXYGEN; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ADULT; ARTICLE; BLOOD OXYGENATION; BLOOD PRESSURE MEASUREMENT; BREATHING PATTERN; CONTROLLED STUDY; ECHO PLANAR IMAGING; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY CORTEX; LATENT PERIOD; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; PERFUSION; PRESSURE MEASUREMENT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; RANDOMIZED CONTROLLED TRIAL; TIME; VASCULARIZATION;

ADULT; ANGIOTENSIN II; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHO-PLANAR IMAGING; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY; MALE; NITROPRUSSIDE; NOREPINEPHRINE; OXYGEN; TIME FACTORS; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 33744989719     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000220109.98142.a3     Document Type: Article

References (22)

1. Simon G, Abraham G. Angiotensin II administration as an experimental model of hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. New York, NY: Raven Press Ltd; 1995:1423-1435.
2. Imig JD. Afferent arteriolar reactivity to angiotensin II is enhanced during the early phase of angiotensin II hypertension. Am J Hypertens. 2000;13:810-818.
3. Stevenson KM, Fitzgerald SM, Evans RG, Anderson WP. Chronic intrarenal infusion of low-dose angiotensin II in dogs increases arterial pressure without impairment of renal function. Clin Exp Pharmacol Physiol. 1997;24:439-441.
4. Fitzgerald SM, Stevenson KM, Evans RG, Anderson WP. Systemic hemodynamic responses to chronic angiotensin II infusion into the renal artery of dogs. Am J Physiol. 1997;273:R1980-R1989.
5. Hall JE, Brands MW, Henegar JR. Angiotensin II and long-term arterial pressure regulation: the overriding dominance of the kidney. J Am Soc Nephrol. 1999;10 (suppl 12):S258-S265.
6. Hall JE, Granger JP. Renal hemodynamic actions of angiotensin II: interaction with tubuloglomerular feedback. Am J Physiol. 1983;245:R166-R173.
7. Juillard L, Lerman LO, Kruger DG, Haas JA, Rucker BC, Polzin JA, Riederer SJ, Romero JC. Blood oxygen level-dependent measurement of acute intra-renal ischemia. Kidney Int. 2004;65:944-950.
8. Pedersen M, Dissing TH, Morkenborg J, Stodkilde-Jorgensen H, Hansen LH, Pedersen LB, Grenier N, Frokiaer J. Validation of quantitative BOLD MRI measurements in kidney: application to unilateral ureteral obstruction. Kidney Int. 2005;67:2305-2312.
9. Schachinger H, Dieterle T, Martina B, Haberthur C, Huber PR, Bock A, Drewe J, Gyr K. Increased renovascular response to angiotensin II in persons genetically predisposed to arterial hypertension disappears after chronic angiotensin-converting enzyme inhibition. J Hypertens. 2004;22:175-180.
10. Hoogenberg K, Smit AJ, Girbes AR. Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers. Crit Care Med. 1998;26:260-265.
11. Schetz M. Vasopressors and the kidney. Blood Purif. 2002;20:243-251.
12. Koller-Strametz J, Wolzt M, Fuchs C, Putz D, Wisser W, Mensik C, Eichler HG, Laufer G, Schmetterer L. Renal hemodynamic effects of L-arginine and sodium nitroprusside in heart transplant recipients. Kidney Int. 1999;55:1871-1877.
13. Ogawa N, Ono H. Different effects of various vasodilators on autoregulation of renal blood flow in anesthetized dogs. Jpn J Pharmacol. 1986;41:299-306.
14. Speck O, Hennig J. Functional imaging by I0- and T2*-parameter mapping using multi-image EPI. Magn Reson Med. 1998;40:243-248.
15. Milnor WR. Cardiovascular Physiology. New York, NY: Oxford University Press; 1990.
16. Navar LG. Renal autoregulation: perspectives from whole kidney and single nephron studies. Am J Physiol. 1978;234:F357-F370.
17. Guyton AC. The relationship of cardiac output and arterial pressure control. Circulation. 1981;64:1079-1088.
18. Stamler JS, Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol Rev. 2001;81:209-237.
19. Noseworthy MD, Bulte DP, Alfonsi J. BOLD magnetic resonance imaging of skeletal muscle. Semin Musculoskelet Radiol. 2003;7:307-315.
20. Jagomagi K, Raamat R, Talts J. Effect of altering vasoactivity on the measurement of finger blood pressure. Blood Press Monit. 2001;6:33-40.
21. Imholz BP, Parati G, Mancia G, Wesseling KH. Effects of graded vasoconstriction upon the measurement of finger arterial pressure. J Hypertens. 1992;10:979-984.
22. Utz W, Jordan J, Niendorf T, Stoffels M, Luft FC, Dietz R, Friedrich MG. Blood oxygen level-dependent MRI of tissue oxygenation: relation to endothelium-dependent and endothelium-independent blood flow changes. Arterioscler Thromb Vasc Biol. 2005;25:1408-1413.